UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Humira permitted for nursing, pregnant patients
The local regulator allowed nursing and pregnant patients to use autoimmune...
by Kim Yun-mi
|
2019-07-11 16:41
라인
SCM Life Science, MitoImmune Therapeutics to develop new treatment
SCM Life Science said that it has agreed with MitoImmune Therapeutics to de...
by Lee Han-soo
|
2019-07-11 16:40
라인
Prosecutors raid 2 lead managers of Kolon TissueGene’s IPO
The prosecution raided two securities firms that managed the initial public...
by Jeong Sae-im
|
2019-07-11 16:39
라인
Acute renal failure reported in ibandronate injections
The government warned that ibandronate injections for the treatment of oste...
by Lee Hye-seon
|
2019-07-11 13:34
라인
Rayence to market new detectors as GE brand
Rayence has announced that it has signed a contract with GE Healthcare to s...
by Lee Han-soo
|
2019-07-11 12:47
라인
NKMax America seeks NASDAQ listing
“Seeking NASDAQ listing as soon as possible, we will show the excellent eff...
by Jeong Sae-im
|
2019-07-11 12:41
라인
Yuyu holds 3rd annual compliance program workshop
Yuyu Pharmaceutical said that it has finished its third annual “Self-Compli...
by Lee Han-soo
|
2019-07-11 12:09
라인
Contera Pharma gets ₩3 billion funding from venture capital
Contera Pharma, a Copenhagen-based subsidiary of Korean drugmaker Bukwang P...
by Jeong Sae-im
|
2019-07-10 17:28
라인
Seoul Medical Center hands over public healthcare tips to Kyrgyzstan
Seoul Medical Center has been offering public healthcare training to Kyrgyz...
by Song Soo-youn
|
2019-07-10 15:20
라인
Psomagen seeks KOSDAQ listing using technology exception policy
Psomagen, a U.S. subsidiary of Macrogen, said it would use Korea’s “technol...
by Jeong Sae-im
|
2019-07-10 15:20
라인
Court to test Nabota’s spore-forming to end Daewoong-Medytoxin dispute
The Seoul Central District Court has begun to test whether Nabota, botulinu...
by Jeong Sae-im
|
2019-07-10 12:44
라인
'Teva's Fremanezumab improves migraine-related disorders, quality of life'
Teva-Handok said that it has presented the exploratory endpoint results of ...
by Lee Han-soo
|
2019-07-09 16:57
라인
‘Doctors know medical data best’
Physicians and data scientists have teamed up to establish Big Data Clinica...
by Kim Eun-young
|
2019-07-09 16:07
라인
ISU Abxis, Kyungpook National University to co-develop Alzheimer's disease treatment
ISU Abxis said it has signed an agreement to co-develop an Alzheimer's ...
by Lee Han-soo
|
2019-07-09 16:06
라인
Sanofi Aventis names new general manager for consumer healthcare
Sanofi Aventis said that it has appointed Fabien Schmitt as the general man...
by Lee Han-soo
|
2019-07-09 15:16
라인
GSK's Alitoc becoming salvation treatment for chronic hand eczema patients
GSK Korea said Tuesday a fast and accurate treatment is needed to cure chro...
by Lee Han-soo
|
2019-07-09 14:44
라인
Kolon files administrative suit against Invossa license revocation
Kolon Life Science said it has filed an administrative lawsuit against the ...
by Jeong Sae-im
|
2019-07-09 11:47
라인
SillaJen shareholders panic over exec’s selling of 160,000 stocks
An executive at SillaJen suddenly sold 160,000 shares for “personal reasons...
by Jeong Sae-im
|
2019-07-09 11:45
라인
SNUH to transfer advanced clinical trial capability to Saudi Arabia
Seoul National University Hospital (SNUH) has signed an agreement with King...
by Lee Han-soo
|
2019-07-08 16:44
라인
61% of doctors oppose telemedicine; survey
Korean physicians remain skeptical about telemedicine even though the natio...
by Song Soo-youn
|
2019-07-08 16:39
-
이전
111
112
113
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top